神经元转化生长因子β通过SMAD3信号传导参与慢性胰腺炎动物模型疼痛
该研究在大鼠和小鼠慢性胰腺炎模型中探究转化生长因子β(TGFB)经SMAD3信号通路对胰腺感觉神经元敏化的作用。结果显示胰腺TGFB过表达或鞘内注射TGFB1引起感觉神经元高兴奋性、SMAD3激活和痛觉增强;而阻断TGFBR2或SMAD3可减轻神经敏化和疼痛行为。鞘内注射TGFB1则减轻痛觉过敏,提示TGFB在外周和中枢对痛觉调控不同。
要点
- 胰腺TGFB过表达或鞘内注射TGFB1导致感觉神经元高兴奋性、SMAD3激活和痛觉增强。
- 阻断TGFBR2或SMAD3可减轻慢性胰腺炎诱导的神经敏化和疼痛行为。
- 鞘内注射TGFB1减轻慢性胰腺炎大鼠痛觉过敏,与外周作用相反。
核心结论
- 小鼠和大鼠胰腺中TGFB通过神经元内SMAD3直接作用于初级感觉神经元促进外周痛觉敏化,这与中枢神经系统中TGFB减轻痛觉的作用不同。
- 该结果解释了慢性胰腺炎患者纤维化与疼痛的关联,该信号通路或可作为治疗靶点以减轻慢性胰腺炎患者疼痛。
研究设计与样本
- 在Sprague-Dawley大鼠中经输注三硝基苯磺酸诱导慢性胰腺炎,部分大鼠接受鞘内输注TGFB1。
- 在对照小鼠中经给予雨蛙素诱导慢性胰腺炎,并研究β1glo/Ptf1acre-ER小鼠(诱导后胰腺腺泡细胞过表达TGFB1)和TGFBr1f/f-CGRPcreER小鼠(诱导性破坏降钙素基因相关肽阳性神经元中的TGFBr1)。
- 通过病毒载体在大鼠胰腺过表达人TGFBR2和SMAD3的显性负性形式,部分大鼠给予SMAD3抑制剂SIS3或卤夫酮。
- 慢性胰腺炎诱导后通过行为测试或感觉神经元电生理研究分析小鼠疼痛,通过膜片钳技术检查胰腺伤害感受器兴奋性,通过Von Frey纤维丝测试检查牵涉性躯体痛觉过敏和对胰腺电刺激的行为反应。
- 收集小鼠和大鼠胰腺进行组织学、酶联免疫吸附测定和免疫组化分析。
主要发现
- 小鼠胰腺腺泡细胞过表达TGFB和大鼠输注TGFB1导致感觉神经元高兴奋性、SMAD3激活和痛觉增强。
- 大鼠胰腺特异性感觉神经元中瞬时A型电流减少,这是慢性胰腺炎动物模型痛觉敏化的特征。
- TGFBr1f/f-CGRPcreER小鼠、胰腺表达人TGFBR2或SMAD3显性负性形式的大鼠以及给予SMAD3小分子抑制剂的大鼠,在慢性胰腺炎诱导后神经敏化和疼痛行为减轻。
- 与外周给予TGFB1不同,鞘内输注TGFB1减轻慢性胰腺炎大鼠的痛觉过敏。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Chronic pancreatitis (CP) is characterized by pancreatic inflammation and fibrosis, associated with increased pancreatic expression of transforming growth factor beta (TGFB). It is not clear how these might contribute to pain. We investigated whether TGFB signaling via SMAD induces sensitization of pancreatic sensory neurons to increase nociception. METHODS: CP was induced in Sprague-Dawley rats by infusion of trinitrobenzene sulfonic acid; some rats were given intrathecal infusions of TGFB1. CP was induced in control mice by administration of cerulein; we also studied β1glo/Ptf1acre-ER mice, which on induction overexpress TGFB1 in pancreatic acinar cells, and TGFBr1f/f-CGRPcreER mice, which have inducible disruption of TGFBr1 in calcitonin gene-related peptide-positive neurons. Dominant negative forms of human TGFBR2 and SMAD3 were overexpressed from viral vectors in rat pancreas. Some rats were given the SMAD3 inhibitors SIS3 or halofuginone. After induction of CP, mice were analyzed for pain in behavior tests or electrophysiologic studies of sensory neurons. Pancreatic nociceptor excitability was examined by patch-clamp techniques and nociception was measured by Von Frey Filament tests for referred somatic hyperalgesia and behavioral responses to pancreatic electrical stimulation. Pancreata were collected from mice and rats and analyzed histologically and by enzyme-linked immunosorbent assay and immunohistochemistry. RESULTS: Overexpression of TGFB in pancreatic acinar cells of mice and infusion of TGFB1 into rats resulted in sensory neuron hyperexcitability, SMAD3 activation, and increased nociception. This was accompanied by a reduction in the transient A-type current in pancreas-specific sensory neurons in rats, a characteristic of nociceptive sensitization in animal models of CP. Conversely, pancreata from TGFBr1f/f-CGRPcreER mice, rats with pancreatic expression of dominant negative forms of human TGFBR2 or SMAD3, and rats given small molecule inhibitors of SMAD3 had attenuated neuronal sensitization and pain behavior following induction of CP. In contrast to findings from peripheral administration of TGFB1, intrathecal infusion of TGFB1 reduced hyperalgesia in rats with CP. CONCLUSIONS: In pancreata of mice and rats, TGFB promotes peripheral nociceptive sensitization via a direct effect on primary sensory neurons mediated by intra-neuronal SMAD3. This is distinct from the central nervous system, where TGFB reduces nociception. These results provide an explanation for the link between fibrosis and pain in patients with CP. This signaling pathway might be targeted therapeutically to reduce pain in patients with CP.
引用
- Liu L, Zhu Y, Noë M, et al. Neuronal Transforming Growth Factor beta Signaling via SMAD3 Contributes to Pain in Animal Models of Chronic Pancreatitis. Gastroenterology. 2018. PMID: 29505748. doi:10.1053/j.gastro.2018.02.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。